166 related articles for article (PubMed ID: 27213244)
1. Influence of metabolism on endocrine activities of bisphenol S.
Skledar DG; Schmidt J; Fic A; Klopčič I; Trontelj J; Dolenc MS; Finel M; Mašič LP
Chemosphere; 2016 Aug; 157():152-9. PubMed ID: 27213244
[TBL] [Abstract][Full Text] [Related]
2. Bisphenol A and its analogs: Do their metabolites have endocrine activity?
Gramec Skledar D; Peterlin Mašič L
Environ Toxicol Pharmacol; 2016 Oct; 47():182-199. PubMed ID: 27771500
[TBL] [Abstract][Full Text] [Related]
3. Suspect and untargeted screening of bisphenol S metabolites produced by in vitro human liver metabolism.
Gys C; Kovačič A; Huber C; Lai FY; Heath E; Covaci A
Toxicol Lett; 2018 Oct; 295():115-123. PubMed ID: 29908846
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay.
Kang JS; Choi JS; Kim WK; Lee YJ; Park JW
Reprod Biol Endocrinol; 2014 Nov; 12():102. PubMed ID: 25371027
[TBL] [Abstract][Full Text] [Related]
5. Profiling of bisphenol S towards nuclear receptors activities in human reporter cell lines.
Zenata O; Dvorak Z; Vrzal R
Toxicol Lett; 2017 Nov; 281():10-19. PubMed ID: 28916285
[TBL] [Abstract][Full Text] [Related]
6. Effects of bisphenol analogs on thyroid endocrine system and possible interaction with 17β-estradiol using GH3 cells.
Lee J; Kim S; Choi K; Ji K
Toxicol In Vitro; 2018 Dec; 53():107-113. PubMed ID: 30099086
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the In Vivo Biotransformation of Two Emerging Estrogenic Contaminants, BP2 and BPS, in Zebrafish Embryos and Adults.
Le Fol V; Brion F; Hillenweck A; Perdu E; Bruel S; Aït-Aïssa S; Cravedi JP; Zalko D
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346357
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol S instead of Bisphenol A: Toxicokinetic investigations in the ovine materno-feto-placental unit.
Grandin FC; Lacroix MZ; Gayrard V; Gauderat G; Mila H; Toutain PL; Picard-Hagen N
Environ Int; 2018 Nov; 120():584-592. PubMed ID: 30212803
[TBL] [Abstract][Full Text] [Related]
9. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors.
Molina-Molina JM; Amaya E; Grimaldi M; Sáenz JM; Real M; Fernández MF; Balaguer P; Olea N
Toxicol Appl Pharmacol; 2013 Oct; 272(1):127-36. PubMed ID: 23714657
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the Metabolic Modification of Environmental Chemicals on Endocrine-disrupting Activity].
Kitamura S
Yakugaku Zasshi; 2018; 138(5):693-713. PubMed ID: 29710015
[TBL] [Abstract][Full Text] [Related]
11. Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes.
Rochester JR; Bolden AL
Environ Health Perspect; 2015 Jul; 123(7):643-50. PubMed ID: 25775505
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease.
Peyre L; Rouimi P; de Sousa G; Héliès-Toussaint C; Carré B; Barcellini S; Chagnon MC; Rahmani R
Food Chem Toxicol; 2014 Aug; 70():9-18. PubMed ID: 24793377
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity.
Li M; Yang Y; Yang Y; Yin J; Zhang J; Feng Y; Shao B
PLoS One; 2013; 8(12):e83170. PubMed ID: 24349450
[TBL] [Abstract][Full Text] [Related]
15. A computational approach predicting CYP450 metabolism and estrogenic activity of an endocrine disrupting compound (PCB-30).
Harris JB; Eldridge ML; Sayler G; Menn FM; Layton AC; Baudry J
Environ Toxicol Chem; 2014 Jul; 33(7):1615-23. PubMed ID: 24687371
[TBL] [Abstract][Full Text] [Related]
16. High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats.
Verner MA; Magher T; Haddad S
Xenobiotica; 2010 Feb; 40(2):83-92. PubMed ID: 19916736
[TBL] [Abstract][Full Text] [Related]
17. The occurrence, potential toxicity, and toxicity mechanism of bisphenol S, a substitute of bisphenol A: A critical review of recent progress.
Qiu W; Zhan H; Hu J; Zhang T; Xu H; Wong M; Xu B; Zheng C
Ecotoxicol Environ Saf; 2019 May; 173():192-202. PubMed ID: 30772709
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of the bisphenol analogue, bisphenol S, in Harlan Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans.
Waidyanatha S; Black SR; Snyder RW; Yueh YL; Sutherland V; Patel PR; Watson SL; Fennell TR
Toxicol Appl Pharmacol; 2018 Jul; 351():32-45. PubMed ID: 29753715
[TBL] [Abstract][Full Text] [Related]
19. Development of an on-line solid phase extraction ultra-high-performance liquid chromatography technique coupled to tandem mass spectrometry for quantification of bisphenol S and bisphenol S glucuronide: Applicability to toxicokinetic investigations.
Grandin F; Picard-Hagen N; Gayrard V; Puel S; Viguié C; Toutain PL; Debrauwer L; Lacroix MZ
J Chromatogr A; 2017 Dec; 1526():39-46. PubMed ID: 29055528
[TBL] [Abstract][Full Text] [Related]
20. Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite.
Skledar DG; Carino A; Trontelj J; Troberg J; Distrutti E; Marchianò S; Tomašič T; Zega A; Finel M; Fiorucci S; Mašič LP
Chemosphere; 2019 Jan; 215():870-880. PubMed ID: 30408883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
